IL-2

Industry

CPC
C07K14/55

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K14/00Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof

Current Industry

C07K14/55IL-2

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Tethered interleukin-2 to its receptor IL-2RBETA, a platform to enh...
- Patent number 12,202,856
- Issue date Jan 21, 2025
- The General Hospital Corporation
- Youssef Jounaidi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Interleukin-2/interleukin-2 receptor alpha fusion proteins and meth...
- Patent number 12,202,872
- Issue date Jan 21, 2025
- Bristol-Myers Squibb Company
- Mary Struthers
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Superagonists, partial agonists and antagonists of interleukin-2
- Patent number 12,202,873
- Issue date Jan 21, 2025
- The Board of Trustees of the Leland Stanford Junior University
- Christopher K. Garcia
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
T-cell modulatory multimeric polypeptides and methods of use thereof
- Patent number 12,180,258
- Issue date Dec 31, 2024
- Cue Biopharma, Inc.
- Ronald D. Seidel
- G01 - MEASURING TESTING
Information Patent Grant
Anti-B7-H4 chimeric antigen receptor-modified NK-92 cells
- Patent number 12,180,283
- Issue date Dec 31, 2024
- ImmunityBio, Inc.
- Hans G. Klingemann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ATP-dependent agonists of immune cells function as anticancer agents
- Patent number 12,180,297
- Issue date Dec 31, 2024
- Crosslink Therapeutics Inc.
- Rodolfo J. Chaparro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified TNF-α antibodies and uses thereof
- Patent number 12,173,062
- Issue date Dec 24, 2024
- Bright Peak Therapeutics AG
- Bertolt Kreft
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Targeting modules for universal chimeric antigen receptor expressin...
- Patent number 12,173,063
- Issue date Dec 24, 2024
- AvenCell Europe GmbH
- Armin Ehninger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Il-2 variants with reduced binding to IL-2 receptor alpha and uses...
- Patent number 12,168,681
- Issue date Dec 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jiaxi Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Enhanced antigen presenting ability of RNA car T cells by co-introd...
- Patent number 12,162,922
- Issue date Dec 10, 2024
- Novartis AG
- Yangbing Zhao
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
T-cell modulatory multimeric polypeptides and methods of use thereof
- Patent number 12,152,061
- Issue date Nov 26, 2024
- Cue Biopharma, Inc.
- Ronald D. Seidel
- G01 - MEASURING TESTING
Information Patent Grant
Interleukin-2 variants and methods of uses thereof
- Patent number 12,152,060
- Issue date Nov 26, 2024
- Cugene Inc.
- Yue-Sheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T-cell modulatory multimeric polypeptides and methods of use thereof
- Patent number 12,145,973
- Issue date Nov 19, 2024
- Cue Biopharma, Inc.
- Ronald D. Seidel
- G01 - MEASURING TESTING
Information Patent Grant
Dual cytokine fusion proteins comprising IL-10
- Patent number 12,145,007
- Issue date Nov 19, 2024
- DEKA BIOSCIENCES INC.
- John Mumm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunostimulating vector system
- Patent number 12,133,898
- Issue date Nov 5, 2024
- Provecs Medical GmbH
- Frank Schnieders
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of lambda interferons in the treatment of obesity-related disor...
- Patent number 12,121,564
- Issue date Oct 22, 2024
- BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS
- Evangelos Andreakos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual cytokine fusion proteins comprising IL-10
- Patent number 12,121,755
- Issue date Oct 22, 2024
- DEKA BIOSCIENCES, INC.
- John Mumm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dual cytokine fusion proteins comprising IL-10
- Patent number 12,122,814
- Issue date Oct 22, 2024
- DEKA BIOSCIENCES, INC.
- John Mumm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dual cytokine fusion proteins comprising IL-10
- Patent number 12,116,390
- Issue date Oct 15, 2024
- DEKA BIOSCIENCES, INC.
- John Mumm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dual cytokine fusion proteins comprising IL-10
- Patent number 12,116,389
- Issue date Oct 15, 2024
- DEKA BIOSCIENCES, INC.
- John Mumm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dual cytokine fusion proteins comprising IL-10
- Patent number 12,116,393
- Issue date Oct 15, 2024
- DEKA BIOSCIENCES, INC.
- John Mumm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dual cytokine fusion proteins comprising IL-10
- Patent number 12,116,391
- Issue date Oct 15, 2024
- DEKA BIOSCIENCES, INC.
- John Mumm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dual cytokine fusion proteins comprising IL-10
- Patent number 12,116,392
- Issue date Oct 15, 2024
- DEKA BIOSCIENCES, INC.
- John Mumm
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Dual cytokine fusion proteins comprising IL-10
- Patent number 12,110,317
- Issue date Oct 8, 2024
- DEKA BIOSCIENCES, INC.
- John Mumm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using interleukin-2 agents
- Patent number 12,098,178
- Issue date Sep 24, 2024
- VISTERRA, INC.
- Scott Moore Carlson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Partial agonists of interleukin-2
- Patent number 12,091,441
- Issue date Sep 17, 2024
- The Board of Trustees of the Leland Stanford Junior University
- Kenan Christopher Garcia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
IL2 and peptide-MHC complex fusion proteins and methods of use thereof
- Patent number 12,091,440
- Issue date Sep 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interleukin-2/interleukin-2 receptor alpha fusion proteins and meth...
- Patent number 12,084,483
- Issue date Sep 10, 2024
- University of Miami
- Thomas Malek
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interleukin-2 agents and uses thereof
- Patent number 12,084,484
- Issue date Sep 10, 2024
- VISTERRA, INC.
- Scott Moore Carlson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered safety in cell therapy
- Patent number 12,076,343
- Issue date Sep 3, 2024
- Innovative Cellular Therapeutics Holdings, Ltd.
- Chengfei Pu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
T-Cell Engaging Polypeptides and Methods of Use Thereof
- Publication number 20250019411
- Publication date Jan 16, 2025
- Cue Biopharma, Inc.
- Anish Suri
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
KIDNEY TARGETED IMMUNOTOLERANCE
- Publication number 20250019431
- Publication date Jan 16, 2025
- PANDION OPERATIONS, INC.
- Bridget LARKIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SYNTHETIC CYTOKINE CIRCUITS TO PROMOTE INFILTRATION AND CLEARANCE O...
- Publication number 20250017963
- Publication date Jan 16, 2025
- The Regents of the University of California
- Wendell A. LIM
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling
- Publication number 20250009824
- Publication date Jan 9, 2025
- KaliVir Immunotherapeutics, Inc.
- Stephen Howard THORNE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CELL SIGNALING COMPLEXES AND USES THEREOF
- Publication number 20250011383
- Publication date Jan 9, 2025
- Nanotein Technologies, Inc.
- Curtis Daniel HODGE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTISPECIFIC ANTIBODIES BINDING TO CD20, NKP46, CD16 AND CONJUGATE...
- Publication number 20250002601
- Publication date Jan 2, 2025
- Innate Pharma
- LAURENT GAUTHIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-2 VARIANTS AND FUSION PROTEINS THEREOF
- Publication number 20250000946
- Publication date Jan 2, 2025
- WUXI BIOLOGICS IRELAND LIMITED
- Lei WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-1 ANTIBODY-ATTENUATED IL-2 IMMUNOCONJUGATES AND USES THEREOF
- Publication number 20240425562
- Publication date Dec 26, 2024
- Cephalon LLC
- David S. WILSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL I...
- Publication number 20240418716
- Publication date Dec 19, 2024
- MeMed Diagnostics Ltd.
- Eran EDEN
- G01 - MEASURING TESTING
Information Patent Application
IL-2 FUSION PROTEINS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC...
- Publication number 20240417453
- Publication date Dec 19, 2024
- Ziyang Zhong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONDITIONALLY ACTIVATED IMMUNOCYTOKINES AND METHODS OF USE
- Publication number 20240417436
- Publication date Dec 19, 2024
- Bright Peak Therapeutics AG
- Vijaya Raghavan PATTABIRAMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Linker Polypeptides
- Publication number 20240417437
- Publication date Dec 19, 2024
- TRUTINO BIOSCIENCES INC.
- Phillip S. Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOKINE ASSOCIATED TUMOR INFILTRATING LYMPHOCYTES COMPOSITIONS AND...
- Publication number 20240408136
- Publication date Dec 12, 2024
- Iovance Biotherapeutics, Inc.
- Frederick G. VOGT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUSION PROTEIN COMPRISING ANTI-CD73 ANTIBODY AND IL-2, AND USE THEREOF
- Publication number 20240408176
- Publication date Dec 12, 2024
- GI INNOVATION, INC.
- Myung Ho JANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSION PROTEIN OF ANTI-TIGIT ANTIBODY AND IL2 OR VARIANT THEREOF AN...
- Publication number 20240400680
- Publication date Dec 5, 2024
- Shanghai Celgen Bio-Pharmaceutical Co., Ltd.
- Yi CHEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PARTIAL AGONISTS OF INTERLEUKIN-2, NUCLEIC ACIDS ENCODING THE SAME,...
- Publication number 20240400631
- Publication date Dec 5, 2024
- The Board of Trustees of the Leland Stanford Junior University
- Kenan Christopher GARCIA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20240400632
- Publication date Dec 5, 2024
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOLIPOPROTEIN FUSION PROTEINS FOR CELL-SPECIFIC IMMUNE REGULATION
- Publication number 20240391978
- Publication date Nov 28, 2024
- Bio-TRIP B.V.
- Roy VAN DER MEEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATORY MOLECULES AND USES THEREOF
- Publication number 20240392004
- Publication date Nov 28, 2024
- IMMUNOWAKE INC.
- Ellen WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC PROTEINS BINDING TO NKP46, A CYTOKINE RECEPTOR, A TUM...
- Publication number 20240392008
- Publication date Nov 28, 2024
- Innate Pharma
- Laurent GAUTHIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND THEIR USES
- Publication number 20240391974
- Publication date Nov 28, 2024
- Ambrx, Inc.
- Sigeng CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use Of Growth Factors For T Cell Activation
- Publication number 20240390420
- Publication date Nov 28, 2024
- CarryGenes Bioengineering, LLC
- Edward L PERKINS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CYTOKINE ASSOCIATED TUMOR INFILTRATING LYMPHOCYTES COMPOSITIONS AND...
- Publication number 20240390424
- Publication date Nov 28, 2024
- Iovance Biotherapeutics, Inc.
- Frederick G. VOGT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INTERLEUKIN-2 MUTANT AND FUSION PROTEIN THEREOF
- Publication number 20240391973
- Publication date Nov 28, 2024
- Fortvita Biologics (Singapore) Pte. Ltd.
- Kaijie HE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NKp46-Targeted Modified IL-2 Polypeptides and Uses Thereof
- Publication number 20240376198
- Publication date Nov 14, 2024
- Inhibrx, Inc.
- John C. Timmer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONDITIONALLY ACTIVATED PROTEINS AND METHODS OF USE
- Publication number 20240376170
- Publication date Nov 14, 2024
- Bright Peak Therapeutics AG
- Vijaya Raghavan PATTABIRAMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROTEASE-ACTIVATED POLYPEPTIDES
- Publication number 20240376171
- Publication date Nov 14, 2024
- HOFFMANN-LA ROCHE INC.
- Samuele CALABRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF
- Publication number 20240376177
- Publication date Nov 14, 2024
- Cue Biopharma, Inc.
- Ronald D. Seidel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN 2 CHIMERIC CONSTRUCTS WITH TARGETING SPECIFICY TO INFLA...
- Publication number 20240376172
- Publication date Nov 14, 2024
- ILTOO PHARMA
- David KLATZMANN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF USING INTERLEUKIN-2 AGENTS
- Publication number 20240376173
- Publication date Nov 14, 2024
- VISTERRA, INC.
- Scott Moore Carlson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Tethered interleukin-2 to its receptor IL-2RBETA, a platform to enh...

Interleukin-2/interleukin-2 receptor alpha fusion proteins and meth...

Superagonists, partial agonists and antagonists of interleukin-2

T-cell modulatory multimeric polypeptides and methods of use thereof

Anti-B7-H4 chimeric antigen receptor-modified NK-92 cells

ATP-dependent agonists of immune cells function as anticancer agents

Modified TNF-α antibodies and uses thereof

Targeting modules for universal chimeric antigen receptor expressin...

Il-2 variants with reduced binding to IL-2 receptor alpha and uses...

Enhanced antigen presenting ability of RNA car T cells by co-introd...

T-cell modulatory multimeric polypeptides and methods of use thereof

Interleukin-2 variants and methods of uses thereof

T-cell modulatory multimeric polypeptides and methods of use thereof

Dual cytokine fusion proteins comprising IL-10

Immunostimulating vector system

Use of lambda interferons in the treatment of obesity-related disor...

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Methods of using interleukin-2 agents

Partial agonists of interleukin-2

IL2 and peptide-MHC complex fusion proteins and methods of use thereof

Interleukin-2/interleukin-2 receptor alpha fusion proteins and meth...

Interleukin-2 agents and uses thereof

Engineered safety in cell therapy

Patents Applicationslast 30 patents

T-Cell Engaging Polypeptides and Methods of Use Thereof

KIDNEY TARGETED IMMUNOTOLERANCE

SYNTHETIC CYTOKINE CIRCUITS TO PROMOTE INFILTRATION AND CLEARANCE O...

Oncolytic Immunotherapy by Tumor Micro-Environment Remodeling

CELL SIGNALING COMPLEXES AND USES THEREOF

MULTISPECIFIC ANTIBODIES BINDING TO CD20, NKP46, CD16 AND CONJUGATE...

IL-2 VARIANTS AND FUSION PROTEINS THEREOF

ANTI-PD-1 ANTIBODY-ATTENUATED IL-2 IMMUNOCONJUGATES AND USES THEREOF

PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL I...

IL-2 FUSION PROTEINS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC...

CONDITIONALLY ACTIVATED IMMUNOCYTOKINES AND METHODS OF USE

Linker Polypeptides

CYTOKINE ASSOCIATED TUMOR INFILTRATING LYMPHOCYTES COMPOSITIONS AND...

FUSION PROTEIN COMPRISING ANTI-CD73 ANTIBODY AND IL-2, AND USE THEREOF

FUSION PROTEIN OF ANTI-TIGIT ANTIBODY AND IL2 OR VARIANT THEREOF AN...

PARTIAL AGONISTS OF INTERLEUKIN-2, NUCLEIC ACIDS ENCODING THE SAME,...

NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

APOLIPOPROTEIN FUSION PROTEINS FOR CELL-SPECIFIC IMMUNE REGULATION

IMMUNOMODULATORY MOLECULES AND USES THEREOF

MULTISPECIFIC PROTEINS BINDING TO NKP46, A CYTOKINE RECEPTOR, A TUM...

INTERLEUKIN-2 POLYPEPTIDE CONJUGATES AND THEIR USES

Use Of Growth Factors For T Cell Activation

CYTOKINE ASSOCIATED TUMOR INFILTRATING LYMPHOCYTES COMPOSITIONS AND...

INTERLEUKIN-2 MUTANT AND FUSION PROTEIN THEREOF

NKp46-Targeted Modified IL-2 Polypeptides and Uses Thereof

CONDITIONALLY ACTIVATED PROTEINS AND METHODS OF USE

PROTEASE-ACTIVATED POLYPEPTIDES

MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF

INTERLEUKIN 2 CHIMERIC CONSTRUCTS WITH TARGETING SPECIFICY TO INFLA...

METHODS OF USING INTERLEUKIN-2 AGENTS